Summary

Report Scope
This report analyzes the digital pathology market, providing forecasted trends and sales projections for this market through 2029. It covers key market players, product segments, supporting technologies, emerging trends, competitive intelligence, major geographies and their competitive landscapes, and it offers regional insights. The report’s in-depth analysis of market dynamics and their impact(s) forms the foundation for its qualitative assessments and market estimates.
Digital pathology is the process of converting glass slide samples into digital images to enable electronic analysis, storage and sharing. This conversion, which enhances diagnostic accuracy, collaboration and efficiency by facilitating advanced imaging, computational analysis and telepathology, has revolutionized pathology with data-driven insights and remote consultations.
While this report outlines the conventional processes of pathology laboratories, it does not include market analysis for traditional lab devices such as microscopes and slides. The connectivity and network issues discussed are specific to data and information related to pathology lab diagnoses, excluding broader hospital-based mHealth (Mobile Health) concerns. This report’s coverage of telepathology is focused on diagnostic applications, research and development (R&D), and education and training but does not address telemedicine at a broader level.
This report addresses regulatory aspects, including innovations; technological advances (patents and approvals); and the latest trends, preferences and developments in digital pathology. As part of its analysis, it segments the digital pathology market by system, type, application and end user. The market has also been segmented into the following major geographies, North America, Asia-Pacific, Europe and the Rest of the World, and there is focused coverage of countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.
Report Includes
- 91 data tables and 57 additional tables
- An analysis of the global market for digital pathology technologies
- Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Descriptions of the upcoming market opportunities for the digital pathology market, factors driving its growth, and forecasts for this market’s segments and sub-segments
- Estimates of the market size and forecasts for the digital pathology market in value (USD millions) terms, and a corresponding market share analysis by system, type, application, end user and geographic region
- In-depth information regarding major market dynamics, technology updates, new products and applications, and COVID-19’s impact on the market for digital pathology
- Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2029
- Information on mergers and acquisitions, agreements, collaborations and product launches in the digital pathology industry
- Analysis of relevant patents
- A discussion of the industry’s ESG challenges and practices
- Analysis of the competitive landscape for digital pathology companies, and a value share analysis based on their segmental revenues and financial performance
- Profiles of the leading global companies, including F. Hoffmann-La Roche Ltd., 3DHISTECH Ltd., Nikon Instruments Inc., Danaher Corp., and Indica Labs Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Market Overview
Historical Development of Digital Pathology
Conventional Process Versus Digital Pathology
Chapter 3 Market Dynamics
Overview
Drivers
Cost-Effectiveness Drives Digital Pathology Expansion
Growing Adoption of Digital Pathology to Enhance Lab Efficiency
Increasing Incidence of Cancer
Increasing Investments and Funding in Digital Pathology
Restraints
Workflow Integration
Slow Implementation of Digital Pathology in Low-Resource Countries
Opportunities
AI in Digital Pathology
Technology Advances
Challenges
Shortage and Unequal Distribution of Pathologists
Data Management
Current Trends in Digital Pathology
Collaborations to Develop Better Solutions
Innovations to Drive Market Growth
Cloud Computing to Enhance Healthcare Delivery Systems
Digital and Computational Pathology
Chapter 4 Regulatory Landscape
Regulatory Environment
U.S.
Europe
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Overview
Market Analysis by System
Digital IVD devices
Digital Pathology Devices
Digital Pathology Analytics
Digital Pathology Communication Platform
Digital Pathology Storage Platform
Telepathology Systems
Market Analysis by Type
Digital Hematology and Clinical Pathology
Digital Anatomical Pathology
Digital Microbiology
Digital Genetic Pathology
Digital Immunopathology
Digital Chemical Pathology
Digital Forensic Pathology
Market Analysis by Application
Disease Diagnosis
Drug Discovery and Development
R&D and Others
Market Analysis by End User
Hospitals and Diagnostic Centers
Biotech and Pharma Companies
Academic Centers and Others
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World
Chapter 6 Emerging Trends and Technologies
Overview
Advances in Multiplexing Methods
Advancing Molecular Pathology
Hyperspectral and Multispectral Imaging
Spatial Biomarker Integration
Whole Slide Digital Imaging
Cloud Computing and Digital Pathology
AI in Digital Pathology
Advances in AI in Digital Pathology in 2024
Chapter 7 ESG Developments
Introduction to ESG
ESG Sustainability in Digital Pathology Market, by Major Manufacturers
ESG Risk Ratings
BCC Research Viewpoint
Chapter 8 Patent Analysis
Overview
Digital Pathology
Chapter 9 Competitive Landscape
Mergers, Acquisitions and Collaborations
Company Share Analysis
Other Key Strategies
Chapter 10 Appendix
Methodology
Sources
Abbreviations
Company Profiles
3DHISTECH LTD.
APOLLO ENTERPRISE IMAGING CORP.
CLINISYS INC.
CORISTA
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
HURON TECHNOLOGIES INTERNATIONAL INC.
INDICA LABS LLC.
KONINKLIJKE PHILIPS N.V.
LEICA BIOSYSTEMS NUSSLOCH GMBH
LIGOLAB INFORMATION SYSTEMS
MIKROSCAN TECHNOLOGIES INC.
NIKON INSTRUMENTS INC.
VISIOPHARM A/S
XIFIN INC.
Emerging Start-ups/Market Disrupters